Trevor Hallam
Exec. VP Research & Dev., PALATIN TECHNOLOGIES INC.
Companies
- Sutro BiopharmaChief Science Officer Sep 26, 2018 to Apr 17, 20231
- PALATIN TECHNOLOGIES INCExec. VP Research & Dev. Oct 11, 2006 to Jul 23, 20102
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Sutro Biopharma STRO100,368 shares3$1.1M at $11.28Apr 14, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 14, 2023Shares withheld for tax 1,296 shares at $4.40 of Sutro Biopharma3
- Apr 14, 2023Exercised options 3,750 shares of Sutro Biopharma3
- Mar 3, 2023Shares withheld for tax 7,717 shares at $5.79 of Sutro Biopharma4
- Mar 3, 2023Exercised options 12,500 shares of Sutro Biopharma4
- Mar 3, 2023Exercised options 9,750 shares of Sutro Biopharma4
- Jan 27, 2023Shares withheld for tax 2,140 shares at $7.50 of Sutro Biopharma5
- Jan 27, 2023Exercised options 5,250 shares of Sutro Biopharma5
- Apr 14, 2022Shares withheld for tax 1,296 shares at $7.26 of Sutro Biopharma6
- Apr 14, 2022Exercised options 3,750 shares of Sutro Biopharma6
- Mar 5, 2022Shares withheld for tax 4,278 shares at $8.17 of Sutro Biopharma7
- Mar 5, 2022Exercised options 12,500 shares of Sutro Biopharma7
- Jan 29, 2022Shares withheld for tax 2,151 shares at $10.39 of Sutro Biopharma8
- Jan 29, 2022Exercised options 5,250 shares of Sutro Biopharma8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Mar 7, 2023
- 5SEC EDGARForm 4 filed Jan 31, 2023
- 6SEC EDGARForm 4 filed Apr 15, 2022
- 7SEC EDGARForm 4 filed Mar 7, 2022
- 8SEC EDGARForm 4 filed Feb 1, 2022